Amakem N.V.
Records under this name other than patents Amakem N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Amakem N.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,682,963 | Pyridine derivatives as soft rock inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,815,873 | Heterocyclic Amides as Rock Inhibitors Formerly held Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 9,394,286 | Rock inhibitors Formerly held Lapsed on the fee record Ended Jul 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 19, 2024 | From the USPTO record |
| US 9,174,939 | Soft rock inhibitors Lapsed on the fee record Ended Nov 3, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2019 | From the USPTO record |
| US 9,126,933 | Soft PDE4 inhibitors Lapsed on the fee record Ended Sep 8, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2019 | From the USPTO record |
| US 9,079,858 | Rock kinase inhibitors Lapsed on the fee record Ended Jul 14, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2019 | From the USPTO record |
| US 9,073,905 | Rock inhibitors Lapsed on the fee record Ended Jul 7, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2019 | From the USPTO record |
| US 9,067,889 | Biphenylcarboxamides as ROCK kinase inhibitors Lapsed on the fee record Ended Jun 30, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2019 | From the USPTO record |
| US 8,912,209 | Novel Rock Inhibitors Lapsed on the fee record Ended Dec 16, 2018 · High confidence | Lapsed on the fee record | Ended Dec 16, 2018 | High confidence |